Are there markers for exceptional responders available for attending pathologists?
CorrespondingAuthor: Sugimura Haruhiko Email: hsugimur@hama-med.ac.jp
DOI: 10.3978/j.issn.2095-6959.2021.11.001
Abstract
In the records of the recent rampant clinical trials, people have noticed there is a fraction, though small, who have extremely good responses to the drugs. The definition of this population “Cancer exceptional responder” is proposed and feasibility study has been launched.